1. Home
  2. SYF vs NTRA Comparison

SYF vs NTRA Comparison

Compare SYF & NTRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SYF
  • NTRA
  • Stock Information
  • Founded
  • SYF 1932
  • NTRA 2003
  • Country
  • SYF United States
  • NTRA United States
  • Employees
  • SYF N/A
  • NTRA N/A
  • Industry
  • SYF Finance: Consumer Services
  • NTRA Medical Specialities
  • Sector
  • SYF Finance
  • NTRA Health Care
  • Exchange
  • SYF Nasdaq
  • NTRA Nasdaq
  • Market Cap
  • SYF 26.7B
  • NTRA 21.7B
  • IPO Year
  • SYF N/A
  • NTRA 2015
  • Fundamental
  • Price
  • SYF $75.51
  • NTRA $168.76
  • Analyst Decision
  • SYF Buy
  • NTRA Strong Buy
  • Analyst Count
  • SYF 19
  • NTRA 16
  • Target Price
  • SYF $71.78
  • NTRA $193.50
  • AVG Volume (30 Days)
  • SYF 2.8M
  • NTRA 992.9K
  • Earning Date
  • SYF 10-15-2025
  • NTRA 11-11-2025
  • Dividend Yield
  • SYF 1.58%
  • NTRA N/A
  • EPS Growth
  • SYF 15.55
  • NTRA N/A
  • EPS
  • SYF 8.21
  • NTRA N/A
  • Revenue
  • SYF $9,185,000,000.00
  • NTRA $1,964,250,000.00
  • Revenue This Year
  • SYF $91.17
  • NTRA $23.93
  • Revenue Next Year
  • SYF $3.50
  • NTRA $15.60
  • P/E Ratio
  • SYF $9.26
  • NTRA N/A
  • Revenue Growth
  • SYF 4.65
  • NTRA 44.38
  • 52 Week Low
  • SYF $40.55
  • NTRA $117.27
  • 52 Week High
  • SYF $77.41
  • NTRA $183.00
  • Technical
  • Relative Strength Index (RSI)
  • SYF 58.32
  • NTRA 56.19
  • Support Level
  • SYF $73.90
  • NTRA $164.83
  • Resistance Level
  • SYF $76.63
  • NTRA $176.82
  • Average True Range (ATR)
  • SYF 1.56
  • NTRA 5.12
  • MACD
  • SYF -0.15
  • NTRA 0.02
  • Stochastic Oscillator
  • SYF 61.32
  • NTRA 46.05

About SYF Synchrony Financial

Synchrony Financial, originally a spinoff of GE Capital's retail financing business, is the largest provider of private-label credit cards in the United States by both outstanding receivables and purchasing volume. Synchrony partners with other firms to market its credit products in their physical stores as well as on their websites and mobile applications. Synchrony operates through three segments: retail card (private-label and co-branded general-purpose credit cards), payment solutions (promotional financing for large ticket purchases), and CareCredit (financing for elective healthcare procedures).

About NTRA Natera Inc.

Natera Inc is a diagnostic and research company with proprietary molecular and bioinformatics technology. The company's key product offerings include its Panorama Non-Invasive Prenatal Test (NIPT) which screens for chromosomal abnormalities of a fetus as well as in twin pregnancies, typically with a blood draw from the mother, Horizon Carrier Screening (HCS) to determine carrier status for a large number of severe genetic diseases that could be passed on to the carrier's children, Signatera molecular residual disease (MRD) test, which detects circulating tumor DNA in patients previously diagnosed with cancer to assess molecular residual disease and monitor for recurrence; and Prospera, to assess organ transplant rejection.

Share on Social Networks: